Bill Moore & his daughter Jessica Oberlin, two members of NAF, recently shared their stories of living with SCA3 as part of a feature for the Critical Path to Therapeutics for the Ataxias (CPTA). The CPTA aims to optimize clinical trials for inherited Ataxias. Impact stories like theirs can help researchers & drug developers understand the realities of living with Ataxia. You can read it here: CPTA — Impact Through Optimization of Clinical Trial Design | Critical Path Institute
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| SCA42 patients? | 4 | 1148 | May 24, 2023 | |
| 🙂 Upcoming March 2024 Webinairs from NAF | 0 | 109 | March 7, 2024 | |
| Report of euro-ATAXIA research conference (3 November 2012) | 5 | 1661 | December 23, 2012 | |
| 🙂 Info re Friedreichs Ataxia..and SCA50 | 0 | 92 | January 23, 2023 | |
| Genetic Testing in the US | 0 | 199 | November 19, 2022 |